COVID-19 | pharmaphorum

Wednesday 1 April 2026

COVID-19

News

GlaxoSmithKline (GSK)

GSK to produce a billion doses of COVID-19 vaccine booster b...

GlaxoSmithKline is to scale up production of its COVID-19 vaccine booster to a billion doses by 2021 to support development of several potential jabs.

News

Gilead Sciences

UK okays early access to Gilead's remdesivir in seriously il...

The UK’s drugs regulator has said that there is enough evidence to support the use of Gilead’s COVID-19 drug remdesivir under its Early Access to Medicines Scheme (EAMS).

Views & Analysis

DeepDive Access and Market

Deep Dive: Market Access - Breaking Barriers

In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.

Views & Analysis

6 ways to digitise your business at pace

6 ways to digitise your business at pace

As the COVID-19 pandemic stretches on, can your business survive without face-to-face customer contact?

Events

JAK Inhibitors Drug Development - Digital Summit

Partner Content

Hit the JAK-pot in global race to treat COVID-19

Hit the JAK-pot in global race to treat COVID-19

News

SARS-CoV-2

Novavax is latest biotech to begin coronavirus vaccine trial

US biotech Novavax has begun a phase 1 study of its coronavirus vaccine, as the number in clinical development reached double figures.